Literature DB >> 22362414

Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.

Matthias B Stope1, Tina Schubert, Doreen Staar, Cindy Rönnau, Andreas Streitbörger, Nils Kroeger, Constanze Kubisch, Uwe Zimmermann, Reinhard Walther, Martin Burchardt.   

Abstract

PURPOSE: Heat shock proteins (HSP) are involved in processes of folding, activation, trafficking and transcriptional activity of most steroid receptors including the androgen receptor (AR). Accumulating evidence links rising heat shock protein 27 (HSP27) levels with the development of castration-resistant prostate cancer. In order to study the functional relationship between HSP27 and the AR, we modulated the expression of the small heat shock protein HSP27 in human prostate cancer (PC) cell lines.
METHODS: HSP27 protein concentrations in LNCaP and PC-3 cells were modulated by over-expression or silencing of HSP27. The effects of HSP27 on AR protein and mRNA levels were monitored by Western blotting and quantitative RT-PCR.
RESULTS: Treatment for the AR-positive LNCaP with HSP27-specific siRNA resulted in a down-regulation of AR levels. This down-regulation of protein was paralleled by a decrease in AR mRNA. Most interestingly, over-expression of HSP27 in PC-3 cells led to a significant increase in AR mRNA although the cells were unable to produce functional AR protein.
CONCLUSION: The observation that HSP27 is involved in the regulation of AR mRNA by a yet unknown mechanism highlights the complexity of HSP27-AR signaling network.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362414     DOI: 10.1007/s00345-012-0843-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells.

Authors:  A Krongrad; C M Wilson; J D Wilson; D R Allman; M J McPhaul
Journal:  Mol Cell Endocrinol       Date:  1991-04       Impact factor: 4.102

2.  Distant metastases from prostatic carcinoma express androgen receptor protein.

Authors:  A Hobisch; Z Culig; C Radmayr; G Bartsch; H Klocker; A Hittmair
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

3.  Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers.

Authors:  F K Storm; D M Mahvi; K W Gilchrist
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

4.  Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.

Authors:  Shalini Murthy; Marco Marcelli; Nancy L Weigel
Journal:  Prostate       Date:  2003-09-01       Impact factor: 4.104

5.  Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.

Authors:  Amina Zoubeidi; Anousheh Zardan; Eliana Beraldi; Ladan Fazli; Richard Sowery; Paul Rennie; Colleen Nelson; Martin Gleave
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

6.  Overexpression of heat shock protein Hsp27 protects against cerulein-induced pancreatitis.

Authors:  Constanze Kubisch; Matthew J Dimagno; Anne Barbara Tietz; Michael J Welsh; Stephen A Ernst; Barbara Brandt-Nedelev; Joachim Diebold; Andreas C C Wagner; Burkhard Göke; John A Williams; Claus Schäfer
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

7.  Autologous down-regulation of androgen receptor messenger ribonucleic acid.

Authors:  V E Quarmby; W G Yarbrough; D B Lubahn; F S French; E M Wilson
Journal:  Mol Endocrinol       Date:  1990-01

8.  DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction.

Authors:  Z Culig; H Klocker; J Eberle; F Kaspar; A Hobisch; M V Cronauer; G Bartsch
Journal:  Prostate       Date:  1993       Impact factor: 4.104

9.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

Authors:  T Visakorpi; E Hyytinen; P Koivisto; M Tanner; R Keinänen; C Palmberg; A Palotie; T Tammela; J Isola; O P Kallioniemi
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

10.  Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Authors:  C Andrieu; D Taieb; V Baylot; S Ettinger; P Soubeyran; A De-Thonel; C Nelson; C Garrido; A So; L Fazli; F Bladou; M Gleave; J L Iovanna; P Rocchi
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

View more
  20 in total

1.  Molecular aspects of prostate cancer.

Authors:  M V Cronauer; Z Culig
Journal:  World J Urol       Date:  2012-03-07       Impact factor: 4.226

2.  Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer.

Authors:  Xiaozhen Liu; Changyun Feng; Junjun Liu; Lin Zhao; Jian Liu; Wei Zhang; Ning Liu; Yun Niu
Journal:  Tumour Biol       Date:  2015-12-28

3.  [Transforming growth factor β in prostate cancer: cellular effects and basic molecular mechanisms].

Authors:  M B Stope; C Rönnau; T Schubert; D Staar; J Bradl; P Ziegler; A Streitbörger; N Kroeger; U Zimmermann; R Walther; M Burchardt; C Börgermann
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

4.  Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.

Authors:  Matthias B Stope; Stefanie Peters; Hannah Großebrummel; Uwe Zimmermann; Reinhard Walther; Martin Burchardt
Journal:  World J Urol       Date:  2014-05-06       Impact factor: 4.226

5.  Physiological and Genetically Engineered Expression Modulation Methods Do Not Affect Cellular Levels of the Heat Shock Protein HSP60 in Prostate Cancer Cells.

Authors:  Holger H H Erb; Andreas Streitbörger; Alexander Mustea; Matthias B Stope
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

6.  Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression.

Authors:  Anja-Martina Rottach; Hannes Ahrend; Benedikt Martin; Reinhard Walther; Uwe Zimmermann; Martin Burchardt; Matthias B Stope
Journal:  World J Urol       Date:  2019-01-02       Impact factor: 4.226

Review 7.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

8.  Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.

Authors:  Yaxin Li; Cody M Orahoske; Werner J Geldenhuys; Asmita Bhattarai; Abboud Sabbagh; Viharika Bobba; Fatma M Salem; Wenjing Zhang; Girish C Shukla; Justin D Lathia; Bingcheng Wang; Bin Su
Journal:  J Med Chem       Date:  2021-02-01       Impact factor: 7.446

Review 9.  Barcoding heat shock proteins to human diseases: looking beyond the heat shock response.

Authors:  Vaishali Kakkar; Melanie Meister-Broekema; Melania Minoia; Serena Carra; Harm H Kampinga
Journal:  Dis Model Mech       Date:  2014-04       Impact factor: 5.758

Review 10.  Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer.

Authors:  Costantine Albany; Noah M Hahn
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.